Inside Drug Pricing - 02/03/2020

State Of The Union Expected To Be The Newsmaker On Drug Pricing This Week

By John Wilkerson, Ariel Cohen / February 3, 2020 at 12:05 PM
The State of the Union address Tuesday (Feb. 4) provides the White House with a prime opportunity to promote its drug pricing agenda. Little is known about the status of the administration’s plan to tie Medicare drug reimbursement to prices abroad, but even if that proposed demonstration isn’t ready for prime time, lobbyists expect the president to say something about his efforts to lower drug prices. Bloomberg reports that Senate Finance Chair Charles Grassley (R-IA) has been coordinating with...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.